Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | EXEL | ASND | ||
| Company | Reata Pharma | Exelixis Inc | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 172.34 | 21.97 | 107.67 | ||
| High | 172.46 | 22.15 | 111.41 | ||
| Low | 172.32 | 21.81 | 106.49 | ||
| Last | 172.36 | 22.00 | 107.69 | ||
| Change | +0.04 | +0.01 | -1.11 | ||
| % Change | +0.02% | +0.05% | -1.02% | ||
| Volume | 1,988,500 | 1,426,300 | 1,471,600 | ||
| 20-Day Average Volume | 810,510 | 1,851,805 | 602,280 | ||
| Previous Close | 172.32 | 21.99 | 108.80 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 21.49 | 97.28 | ||
| 20-Day Raw Stochastic | 97.36% | 75.49% | 85.04% | ||
| 20-Day Relative Strength | 81.56% | 55.37% | 66.67% | ||
| Weighted Alpha | +177.60 | +36.10 | +5.40 | ||
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 16% Buy | Hold | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | +0.27% since 12/01/23 | +3.50% since 12/01/23 | ||
| Low | 171.96 on 09/19/23 | 21.61 on 12/06/23 | 103.01 on 12/04/23 | ||
| High | 172.46 on 09/25/23 | 22.44 on 12/04/23 | 111.41 on 12/08/23 | ||
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | +6.08% since 11/08/23 | +13.67% since 11/08/23 | ||
| Low | 168.67 on 09/05/23 | 20.56 on 11/09/23 | 86.54 on 11/13/23 | ||
| High | 172.46 on 09/25/23 | 22.44 on 12/04/23 | 111.41 on 12/08/23 | ||
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | -0.50% since 09/08/23 | +10.36% since 09/08/23 | ||
| Low | 88.80 on 06/27/23 | 18.64 on 10/23/23 | 85.29 on 10/23/23 | ||
| High | 172.46 on 09/25/23 | 22.51 on 09/28/23 | 111.41 on 12/08/23 | ||
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +13.70% since 06/08/23 | +16.79% since 06/08/23 | ||
| Low | 76.54 on 05/10/23 | 18.64 on 10/23/23 | 85.08 on 06/27/23 | ||
| High | 172.46 on 09/25/23 | 22.80 on 09/01/23 | 111.41 on 12/08/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 6,841,428 | 6,209,405 | ||
| Shares Outstanding, K | 38,150 | 310,974 | 57,660 | ||
| Annual Sales | 2,220,000 | 1,611,060,000 | 53,920,000 | ||
| Annual Net Income | -311,900,000 | 182,280,000 | -614,450,000 | ||
| Last Quarter Sales | 22,750,000 | 471,920,000 | 52,280,000 | ||
| Last Quarter Net Income | 193,000,000 | 1,040,000 | -176,560,000 | ||
| 60-Month Beta | 1.42 | 0.57 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 0.10 on 11/01/23 | -3.12 on 11/07/23 | ||
| Latest Earnings Date | 11/14/23 | 11/01/23 | 11/07/23 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 78.54 | 0.00 | ||
